NIDCD Fellowship and Loan Repayment Program Pre-Application Information Sessions
National Institutes of Health (NIH)
Free. Verify your email, then we send one reminder only.
- Posted
- May 27, 2026
- Closes
- No deadline published by the funder
Amount
Amount not published by the funder
About this opportunity
National Institute on Deafness and Other Communication Disorders (NIDCD) The purpose of this Notice is to announce two virtual information sessions for individuals interested in NIDCD fellowship funding or loan repayment opportunities. NIDCD supports biomedical and behavioral research and research training in the normal and disordered processes of hearing, balance, taste, smell, voice, speech, and language. During the information session, NIDCD staff will provide an overview of available individual fellowship mechanisms, present details related to the application timeline and provide strategies for writing strong applications. Prospective applicants are encouraged to attend and ask questions. An effort will be made to include ample time for questions. The next individual fellowship applica...
Related opportunities
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)National Institutes of HealthCloses May 2028
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)National Institutes of HealthCloses May 2028
- NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)National Institutes of HealthCloses Jan 2028
- NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)National Institutes of HealthCloses in 64 daysUp to $500K
- NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)National Institutes of HealthCloses Jan 2028